EUVIMEDEUVIMED entdecken
Open Access

FTO promotes bladder cancer progression and stemness-associated phenotypes

Naping Wu, Xiaozhou He

Cytotechnology · 2026-06 · 78 (3)

DOI: 10.1007/s10616-026-00971-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytotechnology, online erschienen am 02.05.2026. Verfasst von Naping Wu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, The Third Affiliated Hospital of Soochow University, 185 Juqian Street, Changzhou, 213003 Jiangsu People's Republic of …. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The fat mass and obesity-associated protein (FTO), an N6-methyladenosine (m6A) demethylase, plays a crucial role in various cancers. This study investigates its expression and functional role in bladder cancer (BCa). Analysis of TCGA data and validation in BCa cell lines revealed that FTO is significantly overexpressed in bladder cancer tissues and is associated with poor overall and disease-free survival. Functional assays demonstrated that knockdown of FTO markedly increased global m6A RNA methylation and suppressed the proliferation, migration, invasion, and colony formation of BCa cells in vitro. Furthermore, FTO depletion significantly inhibited tumor growth and experimental liver colonization in nude mouse xenograft models. Mechanistically, transcriptomic analysis of FTO-high patient tissues and FTO-knockdown cells revealed a strong association between FTO and epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) pathways. Consequently, FTO knockdown impaired the self-renewal capacity of BCa cells and downregulated the expression of key stemness genes (CD133, CD44, Nanog, OCT4). These findings suggest FTO is a critical oncoprotein that promotes bladder cancer progression and stemness-associated phenotypes, highlighting its potential as a therapeutic target and prognostic marker.

Schlagwörter

Stichwörter der Autor:innen

Bladder cancerCancer stem cellsEpithelial-mesenchymal transitionFTOM6A modification

Autor:innen und Institutionen

  • Department of Breast Surgery, The Third Affiliated Hospital of Soochow University, 185 Juqian Street, Changzhou, 213003 Jiangsu People's Republic of China.
  • Department of Urology, The Third Affiliated Hospital of Soochow University, 185 Juqian Street, Changzhou, 213003 Jiangsu People's Republic of China.

Zitieren

APA

Wu, N., & He, X. (2026). FTO promotes bladder cancer progression and stemness-associated phenotypes. Cytotechnology, 78(3). https://doi.org/10.1007/s10616-026-00971-3

Vancouver

Wu N, He X. FTO promotes bladder cancer progression and stemness-associated phenotypes. Cytotechnology. 2026;78(3). doi:10.1007/s10616-026-00971-3

BibTeX
@article{Wu2026,
  author = {Wu, Naping and He, Xiaozhou},
  title = {FTO promotes bladder cancer progression and stemness-associated phenotypes},
  journal = {Cytotechnology},
  year = {2026},
  volume = {78},
  number = {3},
  doi = {10.1007/s10616-026-00971-3}
}
Kostenlos starten →